Analysis of grlA mutations in clinical isolates of Staphylococcus aureus with different levels of quinolone resistance

被引：3
|
作者：
Martínez, JA
Ortiz, G
Segovia, M
Alonso, MA
Gutiérrez, MN
Muñoz, JL
García-Rodríguez, JA
机构：
[1] Hosp Gen Univ, Microbiol Serv, Murcia 30003, Spain
[2] Univ Hosp, Microbiol Serv, Salamanca 37007, Spain
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 05期
关键词：
D O I：
10.1128/AAC.42.5.1306
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：1306 / 1307
页数：2
相关论文
共 50 条
  • [1] Mutations in the gyrA and grlA genes of quinolone-resistant clinical isolates of methicillin-resistant Staphylococcus aureus
    Takahata, M
    Yonezawa, M
    Kurose, S
    Futakuchi, N
    Matsubara, N
    Watanabe, Y
    Narita, H
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (03) : 543 - 546
  • [2] Effects of mutations in GrlA of topoisomerase IV from Staphylococcus aureus on quinolone and coumarin activity
    Fournier, B
    Hooper, DC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) : 2109 - 2112
  • [3] grlA and gyrA mutations and antimicrobial susceptibility in clinical isolates of ciprofloxacin-methicillin-resistant Staphylococcus aureus
    Coskun-Ari, F. F.
    Bosgelmez-Tinaz, G.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2008, 13 (08) : 366 - 370
  • [4] Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus
    Takahashi, H
    Kikuchi, T
    Shoji, S
    Fujimura, S
    Lutfor, AB
    Tokue, Y
    Nukiwa, T
    Watanabe, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) : 49 - 57
  • [5] Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus
    Yamagishi, JI
    Kojima, T
    Oyamada, Y
    Fujimoto, K
    Hattori, H
    Nakamura, S
    Inoue, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) : 1157 - 1163
  • [6] Effect of GrlA mutation on the development of quinolone resistance in Staphylococcus aureus in an in vitro pharmacokinetic model
    Oonishi, Yoshimi
    Mitsuyama, Junichi
    Yamaguchi, Keizo
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (05) : 1030 - 1037
  • [7] Quinolone resistance mutations in the GrlB protein of Staphylococcus aureus
    Tanaka, M
    Onodera, Y
    Uchida, Y
    Sato, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 3044 - 3046
  • [8] Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides
    Prunier, AL
    Malbruny, B
    Tandé, D
    Picard, B
    Leclercq, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) : 3054 - 3056
  • [9] Association of mutations in grlA and gyrA topoisomerase genes with resistance to ciprofloxacin in epidemic and sporadic isolates of methicillin-resistant Staphylococcus aureus
    Deplano, A
    Zekhnini, A
    Allali, N
    Couturier, M
    Struelens, MJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 2023 - 2025
  • [10] Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains
    Wang, T
    Tanaka, M
    Sato, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (02) : 236 - 240
12345